Navamedic ASA: Sippcoat granted European patent
Oslo, 20 January 2017 - Navamedic ASA today announced that the European Patent Office has granted a patent for Sippcoat® to be used in any urine handling system to help prevent bacteria migration. This brings with it significant long term commercial potential for Navamedic. "We are pleased to have been granted a European patent for Sippcoat, an innovative encapsulated silicone-oil technology for biofilm inhibition in urine drainage devices. The patent is another exciting development for Navamedic and represents an important milestone in the commercialisation of the Sippi product family.